Mass Gen Hosp Cancer Center — Boston, Massachusetts

Mass Gen Hosp Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass Gen Hosp Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass Gen Hosp Cancer Center?

Mass Gen Hosp Cancer Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass Gen Hosp Cancer Center conducted?

Mass Gen Hosp Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma.

Is Mass Gen Hosp Cancer Center accredited by Crixeo Health?

Mass Gen Hosp Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass Gen Hosp Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.